Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection-Reference-Cited by-同舟云学术

Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection

Published:2021-01-01 Issue:1 Volume:32 Page:1-4
ISSN:2195-4720
Container-title:Pteridines
language:en
Short-container-title:

Author:

Fuchs Dietmar¹,Gisslen Magnus²

Affiliation:

1. Institute of Biological Chemistry , Medical University of Innsbruck , Innsbruck , Austria

2. Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy , University of Gothenburg , Gothenburg , Sweden

Abstract

Abstract The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, prognostic markers could help clinicians to identify patients with a poor outcome early. The serum levels of the immune activation marker neopterin have already been shown to be of prognostic value in patients with SARS-CoV-1 and a similar pattern can be observed for SARS-CoV-2. This comment discusses the biochemical circuits that support the clinical value of neopterin measurements in COVID-19 patients.

Publisher

Walter de Gruyter GmbH

Subject

Clinical Biochemistry,Molecular Medicine,Biochemistry

Link

https://www.degruyter.com/document/doi/10.1515/pteridines-2021-0001/pdf

Reference21 articles.

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr;323(13):1239–42.

2. WHO coronavirus disease (COVID-19) dashboard. 2020, https://covid19.who.int

3. Zheng B, Cao KY, Chan CP, Choi JW, Leung W, Leung M, et al. Serum neopterin for early assessment of severity of severe acute respiratory syndrome. Clin Immunol. 2005 Jul;116(1):18–26.

4. Ozger HS, Dizbay M, Corbacioglu SK, Aysert P, Demirbas Z, Tunccan OG, et al. The prognostic role of neopterin in COVID-19 patients. J Med Virol. 2020 Aug;jmv.26472.

5. Edén A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson LM, et al. CSF biomarkers in patients with COVID-19 and neurological symptoms: A case series. Neurology. 2020 Oct;10:1212.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pterin interactions with gold clusters: A theoretical study;Dyes and Pigments;2023-08

2. Neopterin and kynurenine in serum and urine as prognostic biomarkers in hospitalized patients with delta and omicron variant SARS-CoV-2 infection;Clinical Chemistry and Laboratory Medicine (CCLM);2023-06-09

3. Assessment of Serum Neopterin Levels in patients hospitalized with severe COVID-19;Research Journal of Pharmacy and Technology;2023-04-29

4. Insights into Molecular Structure of Pterins Suitable for Biomedical Applications;International Journal of Molecular Sciences;2022-12-03

5. The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity;Clinical Biochemistry;2022-06